Lundbeck
Lundbeck is a global pharmaceutical company specializing in brain diseases. The company is headquartered in Copenhagen, Denmark, and was founded in 1915 by Hans Lundbeck. Lundbeck is known for its focus on the research, development, production, marketing, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders.
History[edit]
Lundbeck was established in 1915 by Hans Lundbeck as a trading company. Initially, the company dealt with a variety of products, including machinery, aluminum foil, and sweeteners. In the 1920s, Lundbeck began to focus on pharmaceuticals, and by the 1950s, it had become a significant player in the pharmaceutical industry.
Research and Development[edit]
Lundbeck's research and development efforts are primarily focused on brain diseases. The company invests heavily in the development of new treatments for depression, schizophrenia, Alzheimer's disease, Parkinson's disease, and migraine. Lundbeck operates research centers in Denmark and the United States.
Products[edit]
Lundbeck has developed several well-known pharmaceuticals, including:
- Cipralex (escitalopram) - an antidepressant used to treat major depressive disorder and anxiety disorders.
- Abilify Maintena (aripiprazole) - an antipsychotic used for the treatment of schizophrenia and bipolar disorder.
- Brintellix (vortioxetine) - an antidepressant used to treat major depressive disorder.
- Northera (droxidopa) - used to treat neurogenic orthostatic hypotension.
Corporate Structure[edit]
Lundbeck is a publicly traded company listed on the Copenhagen Stock Exchange. The company operates globally, with subsidiaries and offices in over 50 countries. Lundbeck employs approximately 5,000 people worldwide.
Corporate Social Responsibility[edit]
Lundbeck is committed to corporate social responsibility (CSR) and sustainability. The company focuses on ethical business practices, environmental sustainability, and social responsibility. Lundbeck is a member of the United Nations Global Compact and adheres to its principles.
See Also[edit]
- Pharmaceutical industry
- Psychiatric medication
- Neurological disorder
- Depression (mood)
- Schizophrenia
- Alzheimer's disease
- Parkinson's disease
- Migraine
References[edit]
External Links[edit]
-
Lundbeck
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
